ALMR insider transaction filings
Alamar Biosciences, Inc. — 11 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-16. Screen ALMR transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 2 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Brottem John L. — General Counsel | 1 | — | — | 2 |
| RAGUSA ROBERT P — Director | 1 | — | — | 2 |
Recent Form 4 filings — Alamar Biosciences, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | Brottem John L. — General Counsel | Grant/award (A): 29,000 @ $0 · Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | RAGUSA ROBERT P — Director | Grant/award (A): 5,686 @ $0 · Grant/award (A): 25,599 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | Qiming Corporate GP VI, Ltd. — 10% owner Qiming Managing Directors Fund VI, L.P. — 10% owner Qiming Venture Partners VI, L.P. — 10% owner Qiming GP VIII, LLC — 10% owner Qiming Venture Partners VIII Investments, LLC — 10% owner Qiming GP VIII-HC, LLC — 10% owner Qiming Venture Partners VIII-HC, L.P. — 10% owner | Conversion (C): 185,163 · Conversion (C): 6,881,410 · Conversion (C): 1,605,645 · Conversion (C): 1,922,329 · Other (J): 185,163 · Other (J): 6,881,410 · +14 more | EDGAR |
| 2026-04-20 | 4 | Chen Shiping — Chief Operating Officer, Director | Conversion (C): 320,511 · Conversion (C): 72,853 · Other (J): 722,885 · Other (J): 722,885 @ $0 · Grant/award (A): 37,220 @ $0 · Grant/award (A): 163,358 (derivative) @ $0 · +7 more | EDGAR |
| 2026-04-20 | 4 | Luo Yuling — Chief Executive Officer, Director | Conversion (C): 1,386,746 · Conversion (C): 364,268 · Other (J): 1,864,065 · Other (J): 1,864,065 · Grant/award (A): 76,509 @ $0 · Conversion (C): 1,224,152 · +23 more | EDGAR |
| 2026-04-20 | 4 | White Timothy Ogden — President | Other (J): 454,583 · Other (J): 454,583 · Grant/award (A): 37,220 @ $0 · Grant/award (A): 163,358 (derivative) @ $0 · Other (J): 29,357 (derivative) @ $0 · Other (J): 29,357 (derivative) @ $0 · +12 more | EDGAR |
| 2026-04-20 | 4 | Chambers Rebecca — Director | Other (J): 140,612 (derivative) @ $0 · Other (J): 140,612 (derivative) @ $0 | EDGAR |
| 2026-04-20 | 4 | McAnear Justin J. — Chief Financial Officer | Grant/award (A): 37,220 @ $0 · Grant/award (A): 163,358 (derivative) @ $0 · Other (J): 570,719 (derivative) @ $0 · Other (J): 570,719 (derivative) @ $0 | EDGAR |
| 2026-04-20 | 4 | Naclerio Nicholas — Director | Conversion (C): 4,588,364 · Conversion (C): 922,152 · Other (J): 5,510,516 · Other (J): 5,510,516 · Conversion (C): 346,020 · Conversion (C): 271,782 · +9 more | EDGAR |
| 2026-04-20 | 4 | Illumina Innovation Fund II GP, L.L.C. — 10% owner Illumina Innovation Fund II, L.P. — 10% owner Illumina Innovation Fund III GP, L.L.C. — 10% owner Illumina Innovation Fund III, L.P. — 10% owner Naclerio Nicholas — 10% owner | Conversion (C): 4,588,364 · Conversion (C): 922,152 · Other (J): 5,510,516 · Other (J): 5,510,516 · Conversion (C): 346,020 · Conversion (C): 271,782 · +7 more | EDGAR |
| 2026-04-20 | 4 | Witney Frank — Director | Other (J): 49,627 (derivative) @ $0 · Other (J): 49,627 (derivative) @ $0 · Other (J): 33,085 (derivative) @ $0 · Other (J): 33,085 (derivative) @ $0 · Other (J): 124,069 (derivative) @ $0 · Other (J): 124,069 (derivative) @ $0 | EDGAR |
Recent 8-K events — Alamar Biosciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-15 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-20 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALMR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →